GluCl.Cre ON enables selective inhibition of molecularly defined pain circuits. (2023)

First Author: Middleton SJ
Attributed to:  Defining the primary afferent circuitry that drives neuropathic pain funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/j.pain.0000000000002976

PubMed Identifier: 37366588

Publication URI: http://europepmc.org/abstract/MED/37366588

Type: Journal Article/Review

Volume: 164

Parent Publication: Pain

Issue: 12

ISSN: 0304-3959